Your browser doesn't support javascript.
loading
Establishment of fetomaternal tolerance through glycan-mediated B cell suppression.
Rizzuto, G; Brooks, J F; Tuomivaara, S T; McIntyre, T I; Ma, S; Rideaux, D; Zikherman, J; Fisher, S J; Erlebacher, A.
Afiliación
  • Rizzuto G; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
  • Brooks JF; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Tuomivaara ST; Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.
  • McIntyre TI; Center for Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Ma S; Sandler-Moore Mass Spectrometry Core Facility, University of California, San Francisco, CA, USA.
  • Rideaux D; Biomedical Sciences Program, University of California San Francisco, San Francisco, CA, USA.
  • Zikherman J; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Fisher SJ; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Erlebacher A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Nature ; 603(7901): 497-502, 2022 03.
Article en En | MEDLINE | ID: mdl-35236989

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Placenta / Trofoblastos / Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Pregnancy Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Placenta / Trofoblastos / Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Pregnancy Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido